Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.4% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 recruiting1 with results

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06828107Recruiting

A Study to Evaluate the SENSE Device's Ability to Detect TBI

Role: lead

NCT05155800Completed

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

Role: lead

NCT04642443Not ApplicableUnknown

Evaluate the SENSE Device's Ability to Monitor and Detect Intracranial Hemorrhage

Role: lead

NCT03038087Not ApplicableCompleted

A Study to Test the SENSE Device in Patients With Intracranial Hemorrhage

Role: lead

NCT03827720Not ApplicableCompleted

Early Feasibility Study of the SENSE Device

Role: lead

All 5 trials loaded